Acne

Researchers said the treatment is both efficacious and safe in patients ages 9 and older.

The 2 votes came at the end of the second day of a joint meeting of the FDA's Drug Safety and Risk Management Advisory Committee and Dermatologic and Ophthalmic Drugs Advisory Committee.

Researchers say sun exposure plays a role in the exposome of acne-prone skin.

In the final part of this Frontline Forum series, Joshua Zeichner, MD, FAAD; Hilary Baldwin, MD; Zoe Diana Draelos, MD; Aaron S. Farberg, MD, FAAD; and Leon H. Kircik, MD, discuss the main pillars of acne and topical treatments available for patients with acne.

Researchers say adolescents and young adults using the dermocosmetic product experienced improvements in their acne and quality of life.

Experts in dermatology review the dosing and meal requirements need with isotretinoin administration, highlighting the impact and benefit of the novel lidose and micronized formulations.

Linda Stein-Gold, MD and Neal Bhatia, MD discuss their approach to acne management highlighting the novel utility of clascoterone cream 1% and where this fits into their treatment regimens.

In part 3 of this Frontline Forum series, Joshua Zeichner, MD, FAAD; Hilary Baldwin, MD; Zoe Diana Draelos, MD; Aaron S. Farberg, MD, FAAD; and Leon H. Kircik, MD, discuss the main pillars of acne and topical treatments available for patients with acne.

Transgender and cisgender patients presenting with acne face differences in acne treatment and prescribing patterns.

Dawn Eichenfield and Guy Webster discuss considerations relating to treating their patients with clascoterone cream 1%.

Experts in dermatology provide insight into their dosing techniques and how to approach treatment in pediatric and student athlete patients.

Drs Dawn Eichenfield and Guy Webster review their considerations when managing patients with acne, highlighting the need to treat all pathogenic of this condition and properly counseling patients about treatment options.

In part 2 of this Frontline Forum series, Joshua Zeichner, MD, FAAD; Hilary Baldwin, MD; Zoe Diana Draelos, MD; Aaron S. Farberg, MD, FAAD; and Leon H. Kircik, MD, discuss the main pillars of acne and topical treatments available for patients with acne.

Dr Lawrence F. Eichenfield provides his insight into treating acne as a chronic condition and the importance of personalizing a treatment regimen.

Can dietary modifications really improve dermatological conditions?

Lawrence F. Eichenfield, MD, shares his perspectives on the management of acne vulgaris highlighting key topics that were covered in a panel discussion held at Maui Derm 2023.

Data published in Nucleic Acids Research builds on previous studies investigating the benefits of sarecycline for acne vulgaris compared to other antibiotics.

Study investigators evaluated the blood-brain barrier penetrance and lipophilicity of the narrow-spectrum, third-generation tetracycline-class oral antibiotic used for acne treatment.

In part 1 of this Frontline Forum series, Joshua Zeichner, MD, FAAD; Hilary Baldwin, MD; Zoe Diana Draelos, MD; Aaron S. Farberg, MD, FAAD; and Leon H. Kircik, MD, discuss the main pillars of acne and topical treatments available for patients with acne.

Researchers conducted a pooled data analysis using previous study data to determine the cream’s efficacy in patients ages 12 and up.

Emmy Graber, MD, MBA, covered it all in her Winter Clinical Miami talk, offering take-home pearls via patient case studies.

Hilary Baldwin, MD, shares treatment updates and recommendations for acne and rosacea at South Beach Symposium.

A new study also explores why the incidence of acne vulgaris is higher in girls than boys.

Experts at Maui Derm Hawaii offer the latest findings and research in treating acne vulgaris in adolescents.

A poster presentation from Winter Clinical Hawaii evaluated the impact of acne vulgaris on emotional and social functioning among pediatric patients.